Supplementation of Infant Formula and Neurodevelopmental Outcomes: a Systematic Review.


Journal

Current nutrition reports
ISSN: 2161-3311
Titre abrégé: Curr Nutr Rep
Pays: United States
ID NLM: 101587480

Informations de publication

Date de publication:
06 2022
Historique:
accepted: 07 03 2022
pubmed: 26 3 2022
medline: 10 6 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

The aim is to examine data from clinical trials and prospective longitudinal studies that evaluate the effect of infant formula supplements on the cognitive function of children. A total of 300 articles from 2000 to 2021 were selected. The most researched IF supplements were initially long-chain polyunsaturated fatty acids (LC-PUFA), some proteins and, recently, milk fat globule membrane (MFGM). Supplementation of IF with LC-PUFA led to some positive effects on specific cognitive functions or no effect; however, there was no consistent benefit for cognitive function. Modifying the amount of proteins did not affect the children's neuropsychological tests. Supplementation of IF with MFGM and its components had beneficial effects on child cognitive development in the short term, but no effect was observed in the long term. Further studies are needed to confirm the safety of supplementation on the development of cognitive function in children fed with infant formula.

Identifiants

pubmed: 35334102
doi: 10.1007/s13668-022-00410-7
pii: 10.1007/s13668-022-00410-7
doi:

Substances chimiques

Fatty Acids, Unsaturated 0

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-300

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Victoria Arija (V)

Faculty of Medicine and Health Science, Rovira I Virgili University, Tarragona, Spain.
Nutrition and Mental Health Research Group (NUTRISAM), URV, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Cristina Jardí (C)

Faculty of Medicine and Health Science, Rovira I Virgili University, Tarragona, Spain.
Nutrition and Mental Health Research Group (NUTRISAM), URV, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Cristina Bedmar (C)

Faculty of Medicine and Health Science, Rovira I Virgili University, Tarragona, Spain.
Nutrition and Mental Health Research Group (NUTRISAM), URV, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Andrés Díaz (A)

Faculty of Medicine and Health Science, Rovira I Virgili University, Tarragona, Spain.
Nutrition and Mental Health Research Group (NUTRISAM), URV, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Lucía Iglesias (L)

Faculty of Medicine and Health Science, Rovira I Virgili University, Tarragona, Spain.
Nutrition and Mental Health Research Group (NUTRISAM), URV, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Josefa Canals (J)

Faculty of Medicine and Health Science, Rovira I Virgili University, Tarragona, Spain. josefa.canals@urv.cat.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. josefa.canals@urv.cat.
Faculty of Education Sciences and Psychology, Rovira I Virgili University, URV, Ctra. Valls s/n. 43007, Tarragona, Spain. josefa.canals@urv.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH